Becker's Healthcare September 29, 2025
With the release of CMS Star Ratings for 2026 and updates for the upcoming year, Medicare Advantage and Part D plans are navigating an evolving quality landscape. Adherence measures are shifting from triple- to single-weighted and will incorporate risk adjustment, while the MTM Program Completion Rate for CMR enters its second year as a display measure under expanded eligibility criteria. Plans are also still learning what drives success for the new polypharmacy measures.
On the surface, this might suggest medication-focused strategies can be deferred until the 2027 measure year. In reality, doubling down on a smart medication strategy is one of the most important moves a plan can make right now.
Here’s why.
The Pressure of Rising Cut Points and...
Today's Sponsors
Today's Sponsor